537 related articles for article (PubMed ID: 19147572)
41. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB.
Lin RW; Chen CH; Wang YH; Ho ML; Hung SH; Chen IS; Wang GJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):1033-7. PubMed ID: 19150340
[TBL] [Abstract][Full Text] [Related]
42. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity.
Kaler P; Sasazuki T; Shirasawa S; Augenlicht L; Klampfer L
Exp Cell Res; 2008 Apr; 314(7):1507-18. PubMed ID: 18314102
[TBL] [Abstract][Full Text] [Related]
43. Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB.
Funakoshi-Tago M; Shimizu T; Tago K; Nakamura M; Itoh H; Sonoda Y; Kasahara T
Biochem Pharmacol; 2008 Sep; 76(5):662-71. PubMed ID: 18644347
[TBL] [Abstract][Full Text] [Related]
44. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice.
Chiou YS; Ma NJ; Sang S; Ho CT; Wang YJ; Pan MH
J Agric Food Chem; 2012 Apr; 60(13):3441-51. PubMed ID: 22409325
[TBL] [Abstract][Full Text] [Related]
45. Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-kappaB p65 and impairs NF-kappaB activity by inhibiting proteasome activity of cerebellar neurons.
Wang HL; He CY; Chou AH; Yeh TH; Chen YL; Li AH
Cell Signal; 2007 Mar; 19(3):573-81. PubMed ID: 17005371
[TBL] [Abstract][Full Text] [Related]
46. Immune cell activation and subsequent epithelial dysfunction by Staphylococcus enterotoxin B is attenuated by the green tea polyphenol (-)-epigallocatechin gallate.
Watson JL; Vicario M; Wang A; Moreto M; McKay DM
Cell Immunol; 2005 Sep; 237(1):7-16. PubMed ID: 16213476
[TBL] [Abstract][Full Text] [Related]
47. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
Ahmad N; Gupta S; Mukhtar H
Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
[TBL] [Abstract][Full Text] [Related]
48. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
49. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
Wang J; An H; Mayo MW; Baldwin AS; Yarbrough WG
Cancer Cell; 2007 Sep; 12(3):239-51. PubMed ID: 17785205
[TBL] [Abstract][Full Text] [Related]
50. (-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
Morinobu A; Biao W; Tanaka S; Horiuchi M; Jun L; Tsuji G; Sakai Y; Kurosaka M; Kumagai S
Arthritis Rheum; 2008 Jul; 58(7):2012-8. PubMed ID: 18576345
[TBL] [Abstract][Full Text] [Related]
51. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
52. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.
Choi KC; Park S; Lim BJ; Seong AR; Lee YH; Shiota M; Yokomizo A; Naito S; Na Y; Yoon HG
Biochem J; 2011 Jan; 433(1):235-44. PubMed ID: 20955177
[TBL] [Abstract][Full Text] [Related]
53. Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1.
Yan Z; Yong-Guang T; Fei-Jun L; Fa-Qing T; Min T; Ya C
Int J Biochem Cell Biol; 2004 Aug; 36(8):1473-81. PubMed ID: 15147726
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB.
Huang G; Yang Y; Xu Z; Zhou P; Gong W; Li Y; Fan J; He F
Eur J Pharmacol; 2011 Jan; 650(1):451-7. PubMed ID: 20950605
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance.
Assenat E; Gerbal-Chaloin S; Larrey D; Saric J; Fabre JM; Maurel P; Vilarem MJ; Pascussi JM
Hepatology; 2004 Oct; 40(4):951-60. PubMed ID: 15382119
[TBL] [Abstract][Full Text] [Related]
56. Impact of post-translational modifications of proteins on the inflammatory process.
Ito K
Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260
[TBL] [Abstract][Full Text] [Related]
57. Analysis of induction mechanisms of an insulin-inducible transcription factor SHARP-2 gene by (-)-epigallocatechin-3-gallate.
Haneishi A; Takagi K; Asano K; Nakamura S; Yamada K
J Agric Food Chem; 2012 Oct; 60(39):9850-5. PubMed ID: 22967044
[TBL] [Abstract][Full Text] [Related]
58. Impact of protein acetylation in inflammatory lung diseases.
Ito K; Charron CE; Adcock IM
Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
[TBL] [Abstract][Full Text] [Related]
59. MYBBP1a is a novel repressor of NF-kappaB.
Owen HR; Elser M; Cheung E; Gersbach M; Kraus WL; Hottiger MO
J Mol Biol; 2007 Feb; 366(3):725-36. PubMed ID: 17196614
[TBL] [Abstract][Full Text] [Related]
60. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells.
Ho WC; Dickson KM; Barker PA
Cancer Res; 2005 May; 65(10):4273-81. PubMed ID: 15899819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
